(Q47226633)

English

Comparing the antithrombotic efficacy of a humanized anti-factor IX(a) monoclonal antibody (SB 249417) to the low molecular weight heparin enoxaparin in a rat model of arterial thrombosis

scientific article published in October 2000

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

12 January 2018

http://europepmc.org/abstract/MED/11053619

Comparing the antithrombotic efficacy of a humanized anti-factor IX(a) monoclonal antibody (SB 249417) to the low molecular weight heparin enoxaparin in a rat model of arterial thrombosis (English)

1 reference

Europe PubMed Central

12 January 2018

http://europepmc.org/abstract/MED/11053619

1 reference

based on heuristic

inferred from title

author name string

Toomey JR

1

1 reference

Europe PubMed Central

12 January 2018

http://europepmc.org/abstract/MED/11053619

Blackburn MN

2

1 reference

Europe PubMed Central

12 January 2018

http://europepmc.org/abstract/MED/11053619

Storer BL

3

1 reference

Europe PubMed Central

12 January 2018

http://europepmc.org/abstract/MED/11053619

Valocik RE

4

1 reference

Europe PubMed Central

12 January 2018

http://europepmc.org/abstract/MED/11053619

Koster PF

5

1 reference

Europe PubMed Central

12 January 2018

http://europepmc.org/abstract/MED/11053619

Feuerstein GZ

6

1 reference

Europe PubMed Central

12 January 2018

http://europepmc.org/abstract/MED/11053619

publication date

1 October 2000

1 reference

Europe PubMed Central

12 January 2018

http://europepmc.org/abstract/MED/11053619

Thrombosis Research

1 reference

Europe PubMed Central

12 January 2018

http://europepmc.org/abstract/MED/11053619

100

1 reference

Europe PubMed Central

12 January 2018

http://europepmc.org/abstract/MED/11053619

1

1 reference

Europe PubMed Central

12 January 2018

http://europepmc.org/abstract/MED/11053619

73-79

1 reference

Europe PubMed Central

12 January 2018

http://europepmc.org/abstract/MED/11053619

RANDOMISED TRIAL OF INTRAVENOUS STREPTOKINASE, ORAL ASPIRIN, BOTH, OR NEITHER AMONG 17 187 CASES OF SUSPECTED ACUTE MYOCARDIAL INFARCTION: ISIS-2

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900299-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Reactivation of unstable angina after the discontinuation of heparin

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900299-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Aspirin, heparin, and fibrinolytic therapy in suspected acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900299-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Low-molecular-weight heparin : A review of the results of recent studies of the treatment of venous thromboembolism and unstable angina

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900299-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Low-molecular-weight heparins

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900299-1

7 January 2021

based on heuristic

inferred from DOI database lookup

A comparison of low-molecular-weight heparin with unfractionated heparin for unstable coronary artery disease. Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q-Wave Coronary Events Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900299-1

7 January 2021

based on heuristic

inferred from DOI database lookup

A comparison of low-molecular-weight heparin with unfractionated heparin for acute pulmonary embolism. The THESEE Study Group. Tinzaparine ou Heparine Standard: Evaluations dans l'Embolie Pulmonaire

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900299-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Antithrombotic efficacy of a novel murine antihuman factor IX antibody in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900299-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Active site-blocked factor IXa prevents intravascular thrombus formation in the coronary vasculature without inhibiting extravascular coagulation in a canine thrombosis model

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900299-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Targeted inhibition of intrinsic coagulation limits cerebral injury in stroke without increasing intracerebral hemorrhage

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900299-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of low-molecular-weight heparin with unfractionated heparin acutely and with placebo for 6 weeks in the management of unstable coronary artery disease. Fragmin in unstable coronary artery disease study (FRIC)

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900299-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Antithrombotic therapy for venous thromboembolic disease

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900299-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Demonstration of flow and platelet dependency in a ferric chloride-induced model of thrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900299-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0049-3848(00)00299-1

1 reference

Europe PubMed Central

12 January 2018

http://europepmc.org/abstract/MED/11053619

1 reference

Europe PubMed Central

12 January 2018

http://europepmc.org/abstract/MED/11053619

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47226633&oldid=2146840415"